Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New Biotransport formulation of etoposide more effective than currently used formulation

Nov. 2, 2000

Select seeks approval in Canada to begin clinical trials of VeroPulse

Nov. 2, 2000

HGS and Dow to develop radiolabeled BLyS

Nov. 2, 2000

LHRH antagonists particularly useful in hormone-dependent cancer

Oct. 31, 2000

Cyclin/cdk inhibitors synthesized and tested at Albany Molecular Research

Oct. 31, 2000

Inhaled liposomal IL-2 well tolerated in patients with lung metastases

Oct. 31, 2000

Zevalin effective and safe in refractory, heavily pretreated NHL patients

Oct. 30, 2000

Boehringer Ingelheim presents new series of inhibitors of signal transduction

Oct. 30, 2000

Patient enrollment begins in phase I trial of Cotara for colorectal cancer

Oct. 30, 2000

Substituted aza-oxindoles which inhibit protein tyrosine or serine/threonine kinases

Oct. 30, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...